Concepedia

Marko A. Mychaskiw

MA

Statistics

Publications

15

Citations

528

H-Index

13

Active since

2007

Affiliations

Pfizer (United States)(Current)

Teva Pharmaceuticals (United States)

Policy Analysis (United States)

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Zucker Hillside Hospital

Marko A. Mychaskiw is an author at Pfizer (United States) specializing in pharmacy, pharmacotherapy, and psychiatry.

Publications per year

2007–2023

15

Publications

15

Association of subjective anxiety, depression, and sleep disturbance with quality‐of‐life ratings in adults with epilepsy

Patrick Kwan, Evelyn Yu, Howan Leung et al. · Epilepsia · 2008 · 178 citations · Full text

, , +12

Cost-effectiveness of Treating Ocular Hypertension

William C. Stewart, Jeanette A. Stewart, Qasiem J. Nassar et al. · Ophthalmology · 2008 · 62 citations

, , +6

Accounting for Restart Rates in Evaluating Persistence with Ocular Hypotensives

Gail F. Schwartz, Robert W. Platt, Gregory Reardon et al. · Ophthalmology · 2007 · 42 citations · Full text

, , +3

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study

Ariel Berger, John Edelsberg, Kafi N. Sanders et al. · BMC Psychiatry · 2012 · 37 citations · Full text

, , +17

Adherence, Persistence of Use, and Costs Associated With Second-Generation Antipsychotics for Bipolar Disorder

Karen L. Rascati, Kristin M. Richards, Carol A. Ott et al. · Psychiatric Services · 2011 · 33 citations

, , +17

1–5 of 15